Provided by Tiger Trade Technology Pte. Ltd.

AIM ImmunoTech Inc.

0.2136
-0.0093-4.17%
Post-market: 0.21360.00000.00%19:57 EDT
Volume:1.92M
Turnover:410.50K
Market Cap:6.50M
PE:-0.05
High:0.2250
Open:0.2250
Low:0.2120
Close:0.2229
52wk High:2.98
52wk Low:0.1901
Shares:30.44M
Float Shares:30.28M
Volume Ratio:0.31
T/O Rate:6.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9303
EPS(LYR):-30.8884
ROE:-2382.30%
ROA:-82.58%
PB:0.84
PE(LYR):-0.01

Loading ...

AIM ImmunoTech Issues 1,921,441 Shares in $450,000 Debt Exchange with Streeterville Capital

Reuters
·
Sep 11

AIM ImmunoTech Advances Phase 2 Duripanc Trial of Ampligen Plus AstraZeneca’s Imfinzi in Pancreatic Cancer

Reuters
·
Sep 09

AIM ImmunoTech Issues 5,065,840 Shares in Unregistered Note Exchange with Streeterville Capital

Reuters
·
Sep 05

AIM ImmunoTech Expands Ampligen Long COVID Patent Protection Across Europe, UK Through 2041

Reuters
·
Sep 02

AIM ImmunoTech Wins U.S. Patent Covering Ampligen-Keytruda Combo Cancer Therapy Through 2039

Reuters
·
Aug 31

AIM ImmunoTech Secures Broad U.S. Patent for Rintatolimod (Ampligen®) Used in Combination with Pembrolizumab (Keytruda®), Expanding Oncology Ip Protection for Ampligen Through 2039

THOMSON REUTERS
·
Aug 31

Morgans Sticks to Their Hold Rating for Ai-Media Technologies Limited (AIM)

TIPRANKS
·
Aug 28

Boku Tightens Free Float With Latest Share Buyback on AIM

TIPRANKS
·
Aug 27

Windar Photonics Directors Deepen Commitment in AIM Fundraise

TIPRANKS
·
Aug 27

Hargreave Hale AIM VCT Tightens Share Base with Buyback and Cancellation

TIPRANKS
·
Aug 26

PetroTal Non‑Executive Director Boosts Stake With AIM Share Purchase

TIPRANKS
·
Aug 26

Oxford BioDynamics Wins Shareholder Backing for Massive AIM Placing

TIPRANKS
·
Aug 26

Windar Photonics launches £4m equity raise amid accounting probe and AIM suspension

TIPRANKS
·
Aug 24

Trellus Health Appoints Administrators as AIM Delisting Looms

TIPRANKS
·
Aug 24

AIM Vaccine Interim Revenue Slides as Losses Narrow Slightly

TIPRANKS
·
Aug 23

Octopus AIM VCT Updates Voting Rights After Share Buyback

TIPRANKS
·
Aug 20

AIM ImmunoTech Price Target Cut to $7.00/Share from $9.00 by Ascendiant Capital

Dow Jones
·
Aug 20

Franchise Brands CFO Neil Miller Increases Shareholding in AIM-Listed Franchise Group

TIPRANKS
·
Aug 20

PetroTal Director Gavin Wilson Increases Shareholding with AIM Purchase

TIPRANKS
·
Aug 20

Hargreave Hale AIM VCT Cuts Share Count in Latest Buyback

TIPRANKS
·
Aug 19